Literature DB >> 28981380

Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy.

Natalya Kaverina1, Anton V Borovjagin2, Zaira Kadagidze1, Anatoly Baryshnikov3, Maria Baryshnikova3, Dmitry Malin4,5, Dhimankrishhna Ghosh6, Nameeta Shah6, Danny R Welch7, Patrik Gabikian8, Apollon Karseladze9, Charles Cobbs5, Ilya V Ulasov6,10.   

Abstract

Formation of metastases, also known as cancer dissemination, is an important stage of breast cancer (BrCa) development. KISS1 expression is associated with inhibition of metastases development. Recently we have demonstrated that BrCa metastases to the brain exhibit low levels of KISS1 expression at both mRNA and protein levels. By using multicolor immunofluorescence and coculture techniques here we show that normal adult astrocytes in the brain are capable of promoting metastatic transformation of circulating breast cancer cells localized to the brain through secretion of chemokine CXCL12. The latter was found in this study to downregulate KISS1 expression at the post-transcriptional level via induction of microRNA-345 (MIR345). Furthermore, we demonstrated that ectopic expression of KISS1 downregulates ATG5 and ATG7, 2 key modulators of autophagy, and works concurrently with autophagy inhibitors, thereby implicating autophagy in the mechanism of KISS1-mediated BrCa metastatic transformation. We also found that expression of KISS1 in human breast tumor specimens inversely correlates with that of MMP9 and IL8, implicated in the mechanism of metastatic invasion, thereby supporting the role of KISS1 as a potential regulator of BrCa metastatic invasion in the brain. This conclusion is further supported by the ability of KISS1, ectopically overexpressed from an adenoviral vector in MDA-MB-231Br cells with silenced expression of the endogenous gene, to revert invasive phenotype of those cells. Taken together, our results strongly suggest that human adult astrocytes can promote brain invasion of the brain-localized circulating breast cancer cells by upregulating autophagy signaling pathways via the CXCL12-MIR345- KISS1 axis.

Entities:  

Keywords:  KISS1 suppressor; autophagy; brain metastases; breast cancer; stem cells

Mesh:

Substances:

Year:  2017        PMID: 28981380      PMCID: PMC5788498          DOI: 10.1080/15548627.2017.1360466

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  61 in total

1.  ELISA methodology to quantify astrocyte production of cytokines/chemokines in vitro.

Authors:  Hongwei Qin; Etty N Benveniste
Journal:  Methods Mol Biol       Date:  2012

2.  BCL2 suppresses PARP1 function and nonapoptotic cell death.

Authors:  Chaitali Dutta; Tovah Day; Nadja Kopp; Diederik van Bodegom; Matthew S Davids; Jeremy Ryan; Liat Bird; Naveen Kommajosyula; Oliver Weigert; Akinori Yoda; Hua Fung; Jennifer R Brown; Geoffrey I Shapiro; Anthony Letai; David M Weinstock
Journal:  Cancer Res       Date:  2012-06-11       Impact factor: 12.701

3.  Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.

Authors:  Andreas M Stark; Kerrin Tongers; Nicolai Maass; H Maximilian Mehdorn; Janka Held-Feindt
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-08       Impact factor: 4.553

4.  Novel chromophores and buried charges control color in mFruits.

Authors:  Xiaokun Shu; Nathan C Shaner; Corinne A Yarbrough; Roger Y Tsien; S James Remington
Journal:  Biochemistry       Date:  2006-08-15       Impact factor: 3.162

5.  Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.

Authors:  Suqin Zheng; Yanhe Chang; Kurt B Hodges; Ying Sun; Xiaobing Ma; Yi Xue; Sean R Williamson; Antonio Lopez-Beltran; Rodolfo Montironi; Liang Cheng
Journal:  Anticancer Res       Date:  2010-03       Impact factor: 2.480

6.  Clinical significance of KISS1 protein expression for brain invasion and metastasis.

Authors:  Ilya V Ulasov; Natalya V Kaverina; Peter Pytel; Bart Thaci; Feifei Liu; Douglas R Hurst; Danny R Welch; Husein A Sattar; Olufunmilayo I Olopade; Anatoly Y Baryshnikov; Zaira G Kadagidze; Maciej S Lesniak
Journal:  Cancer       Date:  2011-09-16       Impact factor: 6.860

7.  MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo.

Authors:  Ilya Ulasov; Anton V Borovjagin; Natalya Kaverina; Brett Schroeder; Nameeta Shah; Biaoyang Lin; Anatoly Baryshnikov; Charles Cobbs
Journal:  Cancer Lett       Date:  2015-06-04       Impact factor: 8.679

8.  Role of microRNAs in the regulation of breast cancer stem cells.

Authors:  Suling Liu; Shawn G Clouthier; Max S Wicha
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-02-14       Impact factor: 2.673

9.  Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.

Authors:  Antje Lebrecht; Christoph Grimm; Tilmann Lantzsch; Elisabeth Ludwig; Lukas Hefler; Eva Ulbrich; Heinz Koelbl
Journal:  Tumour Biol       Date:  2004 Jan-Apr

10.  Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.

Authors:  Q Wang; Z Jiang; X Qi; S Lu; S Wang; C Leng; F Lu; H Liu; S Liang; J Shi
Journal:  Clin Transl Oncol       Date:  2014-06-04       Impact factor: 3.405

View more
  19 in total

Review 1.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 2.  KISS1 in breast cancer progression and autophagy.

Authors:  Ilya V Ulasov; Anton V Borovjagin; Peter Timashev; Massimo Cristofanili; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

Review 3.  Malignant invasion of the central nervous system: the hidden face of a poorly understood outcome of prostate cancer.

Authors:  Eliane Gouvêa de Oliveira Barros; Nathalia Meireles Da Costa; Celia Yelimar Palmero; Luis Felipe Ribeiro Pinto; Luiz Eurico Nasciutti; Antonio Palumbo
Journal:  World J Urol       Date:  2018-07-06       Impact factor: 4.226

Review 4.  KISS1 in metastatic cancer research and treatment: potential and paradoxes.

Authors:  Thuc Ly; Sitaram Harihar; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 5.  Role of the tumor microenvironment in regulating the anti-metastatic effect of KISS1.

Authors:  Sitaram Harihar; Srijit Ray; Samyukta Narayanan; Anirudh Santhoshkumar; Thuc Ly; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2020-02-22       Impact factor: 5.150

Review 6.  microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy.

Authors:  Ranjana K Kanchan; Jawed A Siddiqui; Sidharth Mahapatra; Surinder K Batra; Mohd W Nasser
Journal:  Mol Cancer       Date:  2020-02-15       Impact factor: 27.401

Review 7.  Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies.

Authors:  Yajie Wang; Fangzhou Ye; Yiran Liang; Qifeng Yang
Journal:  Br J Cancer       Date:  2021-07-05       Impact factor: 9.075

8.  Alpha-lipoic acid inhibits lung cancer growth via mTOR-mediated autophagy inhibition.

Authors:  Peipei Peng; Xiaojin Zhang; Tao Qi; Hao Cheng; Qiuyue Kong; Li Liu; Xiaofei Cao; Zhengnian Ding
Journal:  FEBS Open Bio       Date:  2020-03-18       Impact factor: 2.693

Review 9.  The network of non-coding RNAs and their molecular targets in breast cancer.

Authors:  Francesca Crudele; Nicoletta Bianchi; Eva Reali; Marco Galasso; Chiara Agnoletto; Stefano Volinia
Journal:  Mol Cancer       Date:  2020-03-18       Impact factor: 27.401

10.  Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression.

Authors:  Gehao Liang; Yun Ling; Maryam Mehrpour; Phei Er Saw; Zihao Liu; Weige Tan; Zhenluan Tian; Wenjing Zhong; Wanyi Lin; Qing Luo; Qun Lin; Qiufang Li; You Zhou; Ahmed Hamai; Patrice Codogno; Jun Li; Erwei Song; Chang Gong
Journal:  Mol Cancer       Date:  2020-03-25       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.